University of Cambridge Enterprise logo

University of Cambridge Enterprise

Europe, Cambridgeshire, United Kingdom, Cambridge

Description

Cambridge Enterprise serves as the commercialization arm of the University of Cambridge, dedicated to helping researchers and academics translate their groundbreaking ideas into tangible societal and economic benefits. Its core mission involves managing intellectual property, providing seed funding, and supporting the creation and growth of spin-out companies from the university's research base. This unique position allows Cambridge Enterprise to identify and nurture early-stage innovations across a broad spectrum of sectors, including life sciences, physical sciences, engineering, and information and communication technologies, reflecting the diverse strengths of the university's research portfolio.

The organization operates several seed funds, including the Cambridge Enterprise Seed Funds and the University of Cambridge Enterprise Fund, which provide crucial early-stage capital to nascent ventures. Beyond direct investment, Cambridge Enterprise plays a pivotal role in connecting these emerging companies with external venture capitalists and strategic partners, facilitating larger follow-on funding rounds. Their investment approach is highly hands-on, often involving active participation in the strategic development of their portfolio companies, leveraging their deep understanding of the underlying technologies and the academic environment.

Cambridge Enterprise boasts a significant track record of success, contributing substantially to the vibrant Cambridge innovation ecosystem. In the fiscal year 2022/23 alone, Cambridge Enterprise invested £10.9 million into 39 companies, demonstrating their active commitment to new ventures. Since its inception, their seed funds have collectively invested over £75 million into more than 200 companies, fostering a robust pipeline of innovation. Furthermore, companies spun out of the University of Cambridge have collectively attracted over £5 billion in follow-on investment over the last decade, underscoring the long-term value and attractiveness of the ventures supported by Cambridge Enterprise.

Investor Profile

University of Cambridge Enterprise has backed more than 102 startups, with 0 new investments in the last 12 months alone. The firm has led 37 rounds, about 36% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Pre Seed rounds (top funding stages).
  • Majority of deals are located in United Kingdom, France, Ireland.
  • Strong thematic focus on Biotechnology, Health Care, Software.
  • Typical check size: $100K – $500K.

Stage Focus

  • Seed (42%)
  • Series A (31%)
  • Pre Seed (12%)
  • Series B (8%)
  • Series Unknown (7%)

Country Focus

  • United Kingdom (96%)
  • France (1%)
  • Ireland (1%)
  • United States (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Software
  • Life Science
  • Medical
  • Pharmaceutical
  • Information Technology
  • Artificial Intelligence (Ai)
  • Manufacturing
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does University of Cambridge Enterprise frequently co-invest with?

Martlet Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 15
Molten Ventures
Europe, England, United Kingdom, London
Co-Investments: 4
Cambridge Innovation Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 14
Cambridge Capital Group
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 6
Cambridge Angels group
Europe, England, United Kingdom, London
Co-Investments: 15
Amadeus Capital Partners
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 14
O2h Ventures
Europe, Cambridgeshire, United Kingdom, Hauxton
Co-Investments: 4
IQ Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 10
R42 Group
North America, California, United States, Stanford
Co-Investments: 4
Parkwalk Advisors
Europe, England, United Kingdom, London
Co-Investments: 41

Which angels does University of Cambridge Enterprise often collaborate with?

PH
Europe, Cambridgeshire, United Kingdom, Cambridge
Shared Deals: 1
MG
Europe, England, United Kingdom, London
Shared Deals: 1
David Evans
Oceania, New South Wales, Australia, Sydney
Shared Deals: 1
PF
North America, Massachusetts, United States, Cambridge
Shared Deals: 3
AM
Europe, England, United Kingdom, London
Shared Deals: 2
EM
Europe, Ireland
Shared Deals: 1
JT
Europe, England, United Kingdom, London
Shared Deals: 1
CS
North America, Washington, United States, Kirkland
Shared Deals: 1
PC
Europe, England, United Kingdom, London
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 6

What are some of recent deals done by University of Cambridge Enterprise?

xWatts

London, England, United Kingdom

xWatts is an intelligent energy management system that helps commercial buildings reduce costs and emissions.

Energy ManagementSoftware
Pre SeedJul 18, 2024
Amount Raised: $1,800,000
Wave Photonics

Cambridge, Cambridgeshire, United Kingdom

Wave Photonics utilizes computational techniques to accelerate integrated photonics product designs.

Data IntegrationPredictive AnalyticsSoftware
SeedJun 21, 2024
Amount Raised: $5,692,592
Echion Technologies

Cambridge, Cambridgeshire, United Kingdom

Echion Technologies develops XNO anode materials designed for Li-ion batteries used in heavy-duty electric vehicles.

BatteryManufacturingRenewable Energy
Series BJun 13, 2024
Amount Raised: $37,032,024
Zetta Genomics

Cambridge, Cambridgeshire, United Kingdom

Zetta Genomics manages large-scale genomic data for precision medicine.

BiotechnologyLife ScienceMedicalPrecision Medicine
SeedFeb 8, 2024
Amount Raised: $2,271,758
Xampla

Cambridge, Cambridgeshire, United Kingdom

Xampla develops natural, biodegradable materials as sustainable alternatives to traditional plastics.

BiotechnologyCleanTechPlastics and Rubber Manufacturing
Series BJan 30, 2024
Amount Raised: $6,981,724
T-Therapeutics

Cambridge, Cambridgeshire, United Kingdom

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.

BiotechnologyHealth CareMedical
Series ANov 15, 2023
Amount Raised: $59,626,218
RoboK

Cambridge, Cambridgeshire, United Kingdom

RoboK is a computer vision startup with a mission to make all industrial workplaces safe and high-performing with AI.

Artificial Intelligence (AI)Computer VisionIndustrialPorts and HarborsSoftware
SeedJun 29, 2023
Amount Raised: $1,976,489

Unleashing Virtual Worlds for Indie Gaming Studios.

GamingSaaS
Pre SeedJun 7, 2023
Amount Raised: $1,020,478
PharmEnable

Cambridge, Cambridgeshire, United Kingdom

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

BiotechnologyLife ScienceMedicalPharmaceutical
SeedMay 22, 2023
Amount Raised: $7,460,367
Zetta Genomics

Cambridge, Cambridgeshire, United Kingdom

Zetta Genomics manages large-scale genomic data for precision medicine.

BiotechnologyLife ScienceMedicalPrecision Medicine
SeedApr 17, 2023
Amount Raised: $2,350,970